Press Releases

CAMBRIDGE, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historically undruggable, protein targets driving human disease, today announced the pricing of its upsized initial public offering of 33,500,000 shares of its common stock at a price to the public of $20.00 per share. In addition, Parabilis has granted the underwriters a 30-day option to buy an additional 5,025,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ:VERI) investors of the July 20, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Veritone securities between October 14, 2025 through April 14, 2026 (“the Class Period”).

Gainesville's highest-rated locksmith credits consistent response times, upfront pricing, and a commitment to treating every job like the first as the company crosses 1,313 verified five-star Google reviews.